학술논문
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib with Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)
Document Type
Article
Author
Mayer, E.L.; Burstein, H.J.; Winer, E.P.; Filho, O.M.; Fesl, C.; Hlauschek, D.; Ackerl, K.; Zehetner, K.; Garcia-Estevez, L.; Lorenzo, J.J.P.; Zdenkowski, N.; Wette, V.; Miller, K.D.; Balic, M.; Pristauz-Telsnigg, G.; Mayer, I.A.; Cameron, D.; Traina, T.A.; Lake, D.; Haddad, T.C.; Goetz, M.; Shepherd, L.; Iwata, H.; Cardoso, F.; Sabanathan, D.; Breitenstein, U.; Solomon, K.; El-Abed, S.; Theall, K.P.; Lu, D.R.; Dueck, A.; Gnant, M.; DeMichele, A.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 10 February 2022, 40(5):449-458)
Subject
Language
English
ISSN
15277755
0732183X
0732183X